Sanofi Asks 5th Circ. To Toss Chemo Drug Hair Loss Claims
Sanofi is asking the Fifth Circuit not to revive a suit by a patient alleging the company failed to warn that its chemotherapy drug Taxotere carried a risk of permanent hair...To view the full article, register now.
Already a subscriber? Click here to view full article